| Scientifica | 卷:2026 |
| Explainable Survival Modeling in Pediatric Hematopoietic Stem Cell Transplantation Using Landmark-Based Machine Learning | |
| Research Article | |
| Khawar Siddiqui1  Abdulrahman Al-Musa1  Mona Al-Saleh2  Hawazen Al Saedi1  Abdullah Al-Jefri1  Ibrahim Ghemlas1  Awatif Al Anazi1  Saadiya Khan1  Mouhab Ayas1  Edward De Vol3  Ali Al-Ahmari1  | |
| [1] Research Administrative Operations Department, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, kfshrc.edu.sa | |
| [2] Department of Pediatrics, College of Medicine, Imam Abdulrahman Bin Faisal University, Alkhobar, Saudi Arabia, iau.edu.sa | |
| [3] Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, kfshrc.edu.sa | |
| 关键词: acute GvHD; artificial intelligence; black-box model; global explanation; hematopoietic stem cell transplantation; local explanation; pediatric; sinusoidal obstruction syndrome; survex; veno-occlusive disease; | |
| DOI : 10.1155/sci5/7818238 | |
| received in 2025-01-05, accepted in 2026-04-18, 发布年份 2026 | |
| 来源: Hindawi Publishing Corporation | |
PDF
|
|
【 摘 要 】
BackgroundMachine learning survival models can outperform conventional Cox regression in heterogeneous pediatric HSCT cohorts, but clinical adoption is limited by concerns regarding information leakage, time-dependent structure, and interpretability. We evaluated explainable survival modeling aligned to real-world decision points before transplantation and after early post-transplant complications.Materials and MethodsIn a single-center cohort of 839 transplant-naïve children (< 14 years) undergoing HSCT (2010–2016), overall survival was modeled from infusion to death or last follow-up. A baseline model used only pretransplant variables (age at HSCT, primary diagnostic group, stem cell source, and donor HLA type). To prevent leakage from postinfusion events, a day + 100 landmark cohort (n = 721; 121 deaths beyond day + 100) was constructed and extended with early complications known by day + 100 (SOS/VOD and acute GvHD). Cox proportional hazards, random survival forests (ranger), and randomForestSRC (rfSRC) were benchmarked using C-index, integrated cumulative/dynamic AUC (iAUC), and integrated Brier score (IBS). Cox proportional hazard assumptions were tested using Schoenfeld residuals. Model-agnostic explainability (survex) included time-dependent permutation importance, partial dependence survival profiles, SurvSHAP(t), ceteris paribus profiles, and additive attributions (breakdown and SHAP).ResultsOverall mortality was 28.1% (236/839). Baseline Cox violated proportional hazards (global p=0.00181), whereas the day + 100 landmark Cox did not (global p=0.52). Baseline performance favored ML models (C-index: Cox 0.673, ranger 0.677, rfSRC 0.668; iAUC: 0.698, 0.866, 0.826; IBS: 0.159, 0.126, 0.135). In the landmark setting, discrimination and accuracy improved with ML (C-index: Cox 0.721, ranger 0.870, rfSRC 0.840; iAUC: 0.609, 0.668, 0.650; IBS: 0.125, 0.0969, 0.1016). Explainability analyses produced clinically coherent global and individualized risk narratives beyond day + 100.ConclusionAn information-leakage-free, landmark-based XAI framework allows clinically credible survival prediction in pediatric HSCT, with random survival forests outperforming Cox regression and providing transparent cohort-level and patient-level explanations suitable for clinical communication and risk updating.
【 授权许可】
CC BY
Copyright © 2026 Khawar Siddiqui et al. Scientifica published by John Wiley & Sons Ltd. 2026
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202609140002374ZK.pdf | 3554KB | ||
| Figure 9 | 77KB | Image | |
| Figure 8 | 43KB | Image | |
| Figure 2 | 79KB | Image | |
| Figure 13 | 78KB | Image | |
| Figure 4 | 53KB | Image | |
| Figure 15 | 97KB | Image | |
| Figure 7 | 56KB | Image | |
| Figure 8 | 56KB | Image | |
| Figure 9 | 59KB | Image |
【 图 表 】
Figure 9
Figure 8
Figure 7
Figure 15
Figure 4
Figure 13
Figure 2
Figure 8
Figure 9
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
PDF